Eli Lilly Corp. buy Barclays PLC
Start price
07.02.24
/
50%
€676.00
Target price
07.02.25
€751.76
Performance (%)
1.54%
Price
26.04.24
€685.20
Summary
This prediction is currently active. With a performance of 1.54%, the BUY prediction by Barclays_PLC for Eli Lilly Corp. is trending in the right direction. Dividends of €1.21 are taken into consideration when calculating the performance. This prediction currently runs until 07.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 0.543% | 0.543% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Barclays_PLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Barclays PLC from $680.00 to $810.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Barclays_PLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€580.50
23.01.24
23.01.24
€625.12
23.01.25
23.01.25
18.24%
26.04.24
26.04.24